Back

Is ticagrelor safe in octogenarian patients with non-ST elevation acute coronary syndromes?

European Heart Journal - Cardiovascular Pharmacotherapy

27 October 2017
Organised by: Logo
Read full article
ESC Journals

Contributors

Leonardo De Luca
Leonardo De Luca

Author

Foundation IRCCS Policlinic San Matteo - University of Pavia Pavia , Italy

Stefano De Servi
Stefano De Servi

Author

Giuseppe Musumeci
Giuseppe Musumeci

Author

Leonardo Bolognese
Leonardo Bolognese

Author

You may be interested in
thumbnail
Congress Presentation
Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk
27 August 2022
thumbnail
Congress Presentation
Statin use in octogenarians after a non-ST segment elevation acute coronary syndrome.
2 March 2019
thumbnail
Congress Presentation
The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data
1 September 2024
thumbnail
Congress Presentation
Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources